A well-studied sub-set of the EOAD population are those with a known autosomal dominant AD (AD-AD) mutation in amyloid precursor protein (APP) and presenilin 1 and 2 (PSEN1 and PSEN2) [9,10,11]. Here, PSEN2 is linked to Alzheimer disease.